Zydus Launches IBYRA, the Generic Version of Olaparib, Brings Both Access and Affordability for Cancer Patients in India

Mar 14, 2024

Ahmedabad (Gujarat) [India], March 14: In a significant stride towards making advanced cancer treatment accessible to all, Zydus has launched Olaparib, a PARP inhibitor,...